EUVIMEDEUVIMED entdecken
Open Access

Integrative Multi-Omics Analysis and Experiments Validation Identify COX5B as a Novel Therapeutic Target for Lung Adenocarcinoma

Lv Ling, Minying Lu, Ling Ye, Yuanhang Chen, Sheng Lin, Jun Yang, Yu Rong, Guixiong Wu

Oncology Research · 2026

DOI: 10.32604/or.2025.069889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Lv Ling und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Panyu Hospital of Traditional Chinese Medicine, Guangzhou, 511400, China. Hauptthemen laut MEDLINE: Multiomics, Adenocarcinoma of Lung, Lung Neoplasms, Electron Transport Complex IV. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MultiomicsAdenocarcinoma of LungLung NeoplasmsElectron Transport Complex IVHumansCell Line, TumorAnimalsMicePrognosisOxidative PhosphorylationAdenosine TriphosphateCell ProliferationGene Expression Regulation, NeoplasticComputational BiologyBiomarkers, TumorCells, Cultured

Stichwörter der Autor:innen

Lung adenocarcinoma (LUAD)berberinecytochrome C oxidase 5B (COX5B)prognosisproliferation

Substanzen

COX5B protein, humanCox5a protein, mouseElectron Transport Complex IVAdenosine TriphosphateBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Panyu Hospital of Traditional Chinese Medicine, Guangzhou, 511400, China.
  • Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510095, China.
  • Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • Department of Respiratory Medicine, The People's Hospital of Wuzhou, Wuzhou, 543000, China.

Zitieren

APA

Ling, L., Lu, M., Ye, L., Chen, Y., Lin, S., Yang, J., Rong, Y., & Wu, G. (2026). Integrative Multi-Omics Analysis and Experiments Validation Identify COX5B as a Novel Therapeutic Target for Lung Adenocarcinoma. Oncology Research. https://doi.org/10.32604/or.2025.069889

Vancouver

Ling L, Lu M, Ye L, Chen Y, Lin S, Yang J, et al. Integrative Multi-Omics Analysis and Experiments Validation Identify COX5B as a Novel Therapeutic Target for Lung Adenocarcinoma. Oncology Research. 2026. doi:10.32604/or.2025.069889

BibTeX
@article{Ling2026,
  author = {Ling, Lv and Lu, Minying and Ye, Ling and Chen, Yuanhang and Lin, Sheng and Yang, Jun and Rong, Yu and Wu, Guixiong},
  title = {Integrative Multi-Omics Analysis and Experiments Validation Identify COX5B as a Novel Therapeutic Target for Lung Adenocarcinoma},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2025.069889}
}
Kostenlos starten →